Before flibanserin, there were no FDA-approved treatments for hypoactive sexual desire disorder. The authors clarify the intricacies of an HSDD diagnosis and discuss implications for treatment.
Erin B. Cooper, PhD
Advertisement
Articles by Erin B. Cooper, PhD
Advertisement
Latest Updated Articles
Does Flibanserin Have a Future?Published: January 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Loneliness, Meet Solitude
2
Increased Risk of Death in Patients With Dementia Found Related to Common Hospice Medications
3
How to Approach Conversations With Adult Patients Who Might Have ADHD: New Tools and Insights
4
FDA Approves Uzedy Once-Monthly Extended Release Injectable Suspension for Bipolar I Disorder
5
